Publications

GeorgeYQian/Nha-Trang-Contact-Study-Data-and-Code.

Qian, GY; CLIFFORD, S; FLASCHE, S; Papastylianou, T;

2022

, Github (2022).

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.

ZHENG, B; Green, AC A; Tazare, J; Curtis, HJ; Fisher, L; Nab, L; SCHULTZE, A; MAHALINGASIVAM, V; PARKER, EP K; Hulme, WJ; Bacon, SC J; DeVito, NJ; Bates, C; Evans, D; Inglesby, P; Drysdale, H; Davy, S; Cockburn, J; Morton, CE; Hickman, G; Ward, T; Smith, RM; Parry, J; Hester, F; Harper, S; ... TOMLINSON, LA.

2022

BMJ (Clinical research ed.), (2022).379, 10.1136/bmj-2022-071932.

Science in the time of COVID-19: Reflections on the UK Events Research Programme.

Marteau, TM; Parker, MJ; EDMUNDS, WJ;

2022

Nature Communications, (2022).13 1 10.1038/s41467-022-32366-1.

Demographic characteristics of the reporting study population at enrolment.

Biggs, J; Sy, AK; Ashall, J; Santoso, MS; Brady, OJ; Reyes, MA J; Quinones, MA; Jones-Warner, W; Tandoc, AO; Sucaldito, NL; Huynh, KM; Le, TL; Hung, DT; Nguyen, HA T; Dang, DA; Iwasaki, C; KITAMURA, N; Van Loock, M; Herrera-Taracena, G; Menten, J; Rasschaert, F; Van Wesenbeeck, L; Masyeni, S; Haryanto, S; Yohan, B; ... HIBBERD, ML.

2022

, PLOS Neglected Tropical Diseases (2022).

Public perceptions and interactions with UK COVID-19 Test, Trace and Isolate policies, and implications for pandemic infectious disease modelling.

Marshall, G; Skeva, R; Jay, C; Silva, M; Fyles, M; House, T; Davis, E; Pi, L; MEDLEY, G; Quilty, B; Dyson, L; Yardley, L; FEARON, E;

2022

medRxiv (2022). 10.1101/2022.01.31.22269871.

Using Agent-Based Modelling as an Ex-Post Evaluation Tool to Better Understand the Impact Mechanisms of a Financial Incentives Scheme for Healthcare Providers Working in Maternal and Child Health in Tanzania. Webinar for the International Institute for...

FOSS, A; Mziray, N; Binyaruka, P; Maiba, J; Alibrahim, A; CASSIDY, R; Chalabi, Z; BORGHI, J;

2022

(2022).

Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package - <i>hmer</i>.

Scarponi, D; Iskauskas, A; Clark, R; Vernon, I; McKinley, T; Goldstein, M; Mukandavire, C; Deol, A; WEERASURIYA, C; Bakker, R; WHITE, R; MCCREESH, N;

2022

medRxiv (2022). 10.1101/2022.05.13.22275052.

Association between mobility, non-pharmaceutical interventions, and COVID-19 transmission in Ghana: A modelling study using mobile phone data.

Gibbs, H; LIU, Y; ABBOTT, S; Baffoe-Nyarko, I; Laryea, DO; Akyereko, E; Kuma-Aboagye, P; Asante, IA; Mitjà, O; LSHTM CMMID COVID-19 Working Group,; Ampofo, W; Asiedu-Bekoe, F; MARKS, M; EGGO, RM;

2022

PLOS global public health, (2022).2 9 10.1371/journal.pgph.0000502.

Genomic epidemiology of circulating SARS-CoV-2 variants during first two years of the pandemic in Colombia.

Jimenez-Silva, C; Rivero, R; Douglas, J; Bouckaert, R; Villabona-Arenas, J; ATKINS, K; Gastelbondo, B; Calderon, A; Guzman, C; Echeverri-De la Hoz, D; Muñoz, M; Ballesteros, N; Castañeda, S; Patiño, L; Ramirez, A; Luna, N; Paniz-Mondolfi, A; Serrano-Coll, H; Ramirez, JD; Mattar, S; Drummond, A;

2022

medRxiv (2022). 10.1101/2022.06.20.22275744.

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo.

WATSON-JONES, D; Kavunga-Membo, H; Grais, RF; Ahuka, S; Roberts, N; EDMUNDS, WJ; CHOI, EM; ROBERTS, CH; EDWARDS, T; Camacho, A; LEES, S; Leyssen, M; Spiessens, B; Luhn, K; Douoguih, M; Hatchett, R; Bausch, DG; Muyembe, J-J; DRC-EB-001 protocol writing team,;

2022

BMJ open, (2022).12 3 10.1136/bmjopen-2021-055596.